https://clinicaltrials.gov/study/NCT07290244
https://doi.org/10.1016/S0140-6736(26)01295-X
https://insilico.com/news/az7xmeem81-insilico-medicine-receives-ind-approval?amp=true
https://news.massgeneralbrigham.org/en/pig-kidney-xenotransplant-bridge-to-human-transplant
https://nyulangone.org/news/first-gene-edited-pig-kidney-transplant-clinical-trial-begins-nyu-langone-health
https://nyulangone.org/news/pig-kidney-recipient-returns-home-after-transplant-breakthrough-nyu-langone-health
https://openai.com/index/accelerating-life-sciences-research-with-retro-biosciences/
https://pmc.ncbi.nlm.nih.gov/articles/PMC5654601/
https://pubmed.ncbi.nlm.nih.gov/31378392/
https://pubmed.ncbi.nlm.nih.gov/31542391/
https://pubmed.ncbi.nlm.nih.gov/36599349/
https://pubmed.ncbi.nlm.nih.gov/37541274/
https://pubmed.ncbi.nlm.nih.gov/39904652/
https://pubmed.ncbi.nlm.nih.gov/41620232/
https://www.fda.gov/news-events/press-announcements/fda-approves-first-gene-therapies-treat-patients-sickle-cell-disease
https://www.globenewswire.com/news-release/2020/08/17/2079116/0/en/unity-biotechnology-announces-12-week-data-from-ubx0101-phase-2-clinical-study-in-patients-with-painful-osteoarthritis-of-the-knee.html
https://www.lifebiosciences.com/life-biosciences-announces-first-patient-dosed-in-phase-1-trial-of-er-100-for-optic-neuropathies/
https://www.nature.com/articles/nature19793
https://www.nature.com/articles/s41586-020-2975-4
https://www.nature.com/articles/s41586-021-03819-2
https://www.nature.com/articles/s41586-023-06415-8
https://www.nature.com/articles/s41591-025-03743-2
https://www.nature.com/articles/s41591-025-03743-2.pdf
https://www.nature.com/articles/s42255-025-01387-7
https://www.reuters.com/business/healthcare-pharmaceuticals/google-backed-ai-drug-discovery-startup-isomorphic-labs-delays-clinical-trial-2026-01-20/
https://www.science.org/doi/10.1126/science.ado9336
https://www.youtube.com/watch?v=dQYKcjvXhIY